Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | -8.35% |
|
-14.00% | -58.84% |
| Market Cap | 923K 808K 746K 696K 1.31M 87.23M 1.34M 8.97M 3.46M 43.03M 3.46M 3.39M 149M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.93M -1.69M -1.56M -1.46M -2.75M -183M -2.81M -18.8M -7.26M -90.13M -7.26M -7.1M -313M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -8.35% | ||
| 1 week | -14.00% | ||
| Current month | -6.67% | ||
| 1 month | -3.45% | ||
| 3 months | -3.45% | ||
| 6 months | -56.37% | ||
| Current year | -58.84% |
| 1 week | 0.28 |  | 0.35 |
| 1 month | 0.26 | | 0.44 |
| Current year | 0.15 | | 0.79 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 93.75 |
| 5 years | 0.15 | | 3,161.26 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Free | Company | 111,209 | 3.4934% | ||
| 25-03-30 | Free | Company | 33,724 | 1.6419% | ||
| 24-12-30 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.35% | -14.00% | +16.47% | -99.67% | 923K | |
| +0.13% | -1.33% | +67.18% | +121.93% | 55.63B | |
| +6.76% | +22.83% | +91.66% | +101.42% | 52.25B | |
| +2.50% | +3.83% | -12.05% | -12.49% | 23.07B | |
| +0.59% | +5.80% | +3.66% | +413.41% | 22.41B | |
| +6.78% | +14.47% | +40.28% | -6.67% | 17.32B | |
| +0.97% | +3.81% | +30.68% | -32.21% | 15.94B | |
| -0.58% | +6.17% | +23.70% | +187.55% | 13.77B | |
| +9.96% | +19.81% | +157.65% | +320.70% | 13.47B | |
| +4.21% | +4.76% | +33.21% | - | 12.43B | |
| Average | +2.29% | +4.76% | +45.24% | +110.44% | 22.63B | |
| Weighted average by Cap. | +3.28% | +7.62% | +54.71% | +127.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.23 1.13 1.06 1.99 132.74 2.04 13.66 5.27 65.49 5.27 5.16 227.36 |
| Net income | -11.65M -10.2M -9.42M -8.8M -16.56M -1.1B -16.93M -113M -43.76M -543M -43.76M -42.8M -1.89B | -2.91M -2.55M -2.35M -2.2M -4.13M -275M -4.23M -28.3M -10.92M -136M -10.92M -10.68M -471M |
| Net Debt | -2.59M -2.27M -2.1M -1.96M -3.69M -245M -3.77M -25.23M -9.74M -121M -9.74M -9.53M -420M | -2.86M -2.5M -2.31M -2.16M -4.06M -270M -4.15M -27.77M -10.72M -133M -10.72M -10.49M -462M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | US$0.2800 | -8.35% | 658 |
| 26-06-25 | US$0.3055 | -12.71% | 3,117 |
| 26-06-24 | US$0.3500 | +9.37% | 5,439 |
| 26-06-23 | US$0.3200 | +6.67% | 2,997 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
